Finally, we recognize the need to further investigate the relationship between CA125 and cardiovascular events in patients with gastric cancer, including brain natriuretic peptide, which is a heart failure marker, and ejection fraction, which is a heart function indicator. The gene discussed is NPPB; the disease is gastric cancer.